Targeting Minimal Residual Disease in Solid Tumors: Challenges and Opportunities

Time: 1:45 pm
day: Bootcamp Day


• Understand why targeting minimal residual disease in solid tumors provides a significant therapeutic opportunity
• Outline the genomic and transcriptomic make up of MRD in ovarian cancer
• Describe how MRD is likely to interact with the tumor microenvironment